UnknownPhase 4NCT05581576

Pitolisant in Refractory Restless Legs Syndrome

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
William Ondo, MD
Principal Investigator
William Ondo, MD
The Methodist Hospital Research Institute
Intervention
Pitolisant(drug)
Enrollment
18 enrolled
Eligibility
21-80 years · All sexes
Timeline
20222023

Study locations (1)

Collaborators

Harmony Biosciences Management, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05581576 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome

← Back to all trials